174 related articles for article (PubMed ID: 17945191)
1. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids.
Siemoneit U; Hofmann B; Kather N; Lamkemeyer T; Madlung J; Franke L; Schneider G; Jauch J; Poeckel D; Werz O
Biochem Pharmacol; 2008 Jan; 75(2):503-13. PubMed ID: 17945191
[TBL] [Abstract][Full Text] [Related]
2. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.
Safayhi H; Mack T; Sabieraj J; Anazodo MI; Subramanian LR; Ammon HP
J Pharmacol Exp Ther; 1992 Jun; 261(3):1143-6. PubMed ID: 1602379
[TBL] [Abstract][Full Text] [Related]
3. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense.
Tausch L; Henkel A; Siemoneit U; Poeckel D; Kather N; Franke L; Hofmann B; Schneider G; Angioni C; Geisslinger G; Skarke C; Holtmeier W; Beckhaus T; Karas M; Jauch J; Werz O
J Immunol; 2009 Sep; 183(5):3433-42. PubMed ID: 19648270
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the immune system by Boswellia serrata extracts and boswellic acids.
Ammon HP
Phytomedicine; 2010 Sep; 17(11):862-7. PubMed ID: 20696559
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
Safayhi H; Sailer ER; Ammon HP
Mol Pharmacol; 1995 Jun; 47(6):1212-6. PubMed ID: 7603462
[TBL] [Abstract][Full Text] [Related]
6. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.
Siemoneit U; Pergola C; Jazzar B; Northoff H; Skarke C; Jauch J; Werz O
Eur J Pharmacol; 2009 Mar; 606(1-3):246-54. PubMed ID: 19374837
[TBL] [Abstract][Full Text] [Related]
7. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase.
Poeckel D; Tausch L; Kather N; Jauch J; Werz O
Mol Pharmacol; 2006 Sep; 70(3):1071-8. PubMed ID: 16788089
[TBL] [Abstract][Full Text] [Related]
8. Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interference.
Henkel A; Kather N; Mönch B; Northoff H; Jauch J; Werz O
Biochem Pharmacol; 2012 Jan; 83(1):115-21. PubMed ID: 22001311
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid.
Bishnoi M; Patil CS; Kumar A; Kulkarni SK
Indian J Exp Biol; 2006 Feb; 44(2):128-32. PubMed ID: 16480179
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice.
Bishnoi M; Patil CS; Kumar A; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2005 Sep; 27(7):465-70. PubMed ID: 16258590
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of ketoprofen.
Levoin N; Blondeau C; Guillaume C; Grandcolas L; Chretien F; Jouzeau JY; Benoit E; Chapleur Y; Netter P; Lapicque F
Biochem Pharmacol; 2004 Nov; 68(10):1957-69. PubMed ID: 15476667
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice.
Bishnoi M; Patil CS; Kumar A; Kulkarni SK
Pharmacology; 2007; 79(1):34-41. PubMed ID: 17139192
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by boswellic acids of human leukocyte elastase.
Safayhi H; Rall B; Sailer ER; Ammon HP
J Pharmacol Exp Ther; 1997 Apr; 281(1):460-3. PubMed ID: 9103531
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Pgp function by boswellic acids.
Weber CC; Reising K; Müller WE; Schubert-Zsilavecz M; Abdel-Tawab M
Planta Med; 2006 May; 72(6):507-13. PubMed ID: 16773534
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense.
Siemoneit U; Koeberle A; Rossi A; Dehm F; Verhoff M; Reckel S; Maier TJ; Jauch J; Northoff H; Bernhard F; Doetsch V; Sautebin L; Werz O
Br J Pharmacol; 2011 Jan; 162(1):147-62. PubMed ID: 20840544
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory potential of 2-styrylchromones regarding their interference with arachidonic acid metabolic pathways.
Gomes A; Fernandes E; Silva AM; Pinto DC; Santos CM; Cavaleiro JA; Lima JL
Biochem Pharmacol; 2009 Jul; 78(2):171-7. PubMed ID: 19464432
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins.
Gerbeth K; Hüsch J; Fricker G; Werz O; Schubert-Zsilavecz M; Abdel-Tawab M
Fitoterapia; 2013 Jan; 84():99-106. PubMed ID: 23103296
[TBL] [Abstract][Full Text] [Related]
18. Impact of para-phenylenediamine on cyclooxygenases expression and prostaglandin formation in human immortalized keratinocytes (HaCaT).
Moeller R; Lichter J; Blömeke B
Toxicology; 2008 Jul; 249(2-3):167-75. PubMed ID: 18571826
[TBL] [Abstract][Full Text] [Related]
19. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(®)) of Boswellia extract.
Hüsch J; Bohnet J; Fricker G; Skarke C; Artaria C; Appendino G; Schubert-Zsilavecz M; Abdel-Tawab M
Fitoterapia; 2013 Jan; 84():89-98. PubMed ID: 23092618
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.
Sailer ER; Schweizer S; Boden SE; Ammon HP; Safayhi H
Eur J Biochem; 1998 Sep; 256(2):364-8. PubMed ID: 9760176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
